JP2013530208A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530208A5 JP2013530208A5 JP2013517583A JP2013517583A JP2013530208A5 JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5 JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013517583 A JP2013517583 A JP 2013517583A JP 2013530208 A5 JP2013530208 A5 JP 2013530208A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- topical administration
- administration
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 230000000699 topical Effects 0.000 claims 12
- 210000000088 Lip Anatomy 0.000 claims 6
- 239000002202 Polyethylene glycol Substances 0.000 claims 5
- 229920001223 polyethylene glycol Polymers 0.000 claims 5
- 208000004898 Herpes Labialis Diseases 0.000 claims 3
- 206010067152 Oral herpes Diseases 0.000 claims 3
- 210000003491 Skin Anatomy 0.000 claims 2
- 201000009910 diseases by infectious agent Diseases 0.000 claims 2
- 230000001815 facial Effects 0.000 claims 2
- 206010047461 Viral infection Diseases 0.000 claims 1
- 208000001756 Virus Disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000017613 viral reproduction Effects 0.000 claims 1
Claims (16)
- 局所投与によって、口唇ヘルペスの再発率を低下させ、再発を遅らせ、および/または再発を予防する方法に使用するためのポリエチレングリコールを含む医薬組成物であって、投与期間が少なくとも４週間である、前記医薬組成物。
- 投与期間が少なくとも８週間である、請求項１に記載の医薬組成物。
- 投与期間が少なくとも３ヶ月である、請求項１に記載の医薬組成物。
- 局所投与によって、口唇ヘルペスの再発率を低下させるための、請求項１〜３のいずれか１つに記載の医薬組成物。
- 局所投与によって、口唇ヘルペスの再発を遅らせるための、請求項１〜３のいずれか１つに記載の医薬組成物。
- 局所投与によって、口唇ヘルペスの再発を予防するための、請求項１〜３のいずれか１つに記載の医薬組成物。
- 活動性ウイルス感染を示す1つもしくは複数の部位、または活動性の感染の兆候はないが活動性の感染が起こると判明している、もしくは予想される部位に対して、局所投与が行われる、請求項１〜６のいずれか１つに記載の医薬組成物。
- 局所投与が、治療すべき患者の口唇上、および/またはその周囲に行われる、請求項１〜６のいずれか１つに記載の医薬組成物。
- 局所投与が、治療すべき患者の口唇の少なくとも一部、および口唇の縁から<1 cmの周囲の顔面皮膚に対して行われる、請求項１〜６のいずれか１つに記載の医薬組成物。
- 局所投与が、治療すべき患者の上下の口唇全体に対して行われる、請求項１〜６のいずれか１つに記載の医薬組成物。
- 局所投与が、治療すべき患者の上下の口唇全体、および口唇の縁から<1 cmの周囲の顔面皮膚に対して行われる、請求項１〜６のいずれか１つに記載の医薬組成物。
- 局所投与が、１日１回から１日５回までである、請求項１〜１１のいずれか１つに記載の医薬組成物。
- 局所投与が、１日１回から１日３回までである、請求項１〜１１のいずれか１つに記載の医薬組成物。
- 局所投与が１日２回である、請求項１〜１１のいずれか１つに記載の医薬組成物。
- ポリエチレングリコールが200から20,000までの重量平均分子量（Mw）を有する、請求項１〜１４のいずれか１つに記載の医薬組成物。
- ポリエチレングリコールが、200から1,000までの重量平均分子量（Mw）を有するポリエチレングリコールである；または1,000から15,000までの重量平均分子量（Mw）を有するポリエチレングリコールである；またはそれらの混合物である、請求項１〜１４のいずれか１つに記載の医薬組成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36232910P | 2010-07-08 | 2010-07-08 | |
| US61/362,329 | 2010-07-08 | ||
| PCT/IB2011/001919 WO2012004669A1 (en) | 2010-07-08 | 2011-07-08 | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530208A JP2013530208A (ja) | 2013-07-25 |
| JP2013530208A5 true JP2013530208A5 (ja) | 2014-07-31 |
| JP5858994B2 JP5858994B2 (ja) | 2016-02-10 |
Family
ID=44588123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517583A Active JP5858994B2 (ja) | 2010-07-08 | 2011-07-08 | 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9814743B2 (ja) |
| EP (1) | EP2563374B1 (ja) |
| JP (1) | JP5858994B2 (ja) |
| KR (1) | KR101881175B1 (ja) |
| CN (1) | CN103079574B (ja) |
| AU (1) | AU2011275458B2 (ja) |
| CA (1) | CA2803228C (ja) |
| DK (1) | DK2563374T3 (ja) |
| ES (1) | ES2442928T3 (ja) |
| HK (1) | HK1180969A1 (ja) |
| HR (1) | HRP20140135T1 (ja) |
| IL (1) | IL223582A (ja) |
| MX (1) | MX2012014783A (ja) |
| PL (1) | PL2563374T3 (ja) |
| PT (1) | PT2563374E (ja) |
| RS (1) | RS53162B (ja) |
| RU (1) | RU2643763C2 (ja) |
| SG (1) | SG186937A1 (ja) |
| SI (1) | SI2563374T1 (ja) |
| WO (1) | WO2012004669A1 (ja) |
| ZA (1) | ZA201300177B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2563374T3 (da) | 2010-07-08 | 2014-01-20 | Devirex Ag | Polyethylenglycolsammensætninger til kontrol af tilbagefald af herpes labialis, herpes genitalis og herpes zoster |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| US9084740B2 (en) | 2013-02-19 | 2015-07-21 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
| ES2538335T3 (es) * | 2013-05-14 | 2015-06-19 | Najöpharm Gmbh I.G. | Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes |
| WO2018095576A1 (en) * | 2016-11-28 | 2018-05-31 | Aicuris Anti-Infective Cures Gmbh | Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| WO2021233571A1 (de) * | 2020-04-30 | 2021-11-25 | Ninoderm Ug (Haftungsbeschränkt) | Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603122A (en) * | 1979-08-17 | 1986-07-29 | Blough Herbert A | Antiviral agent against herpes virus infections |
| GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
| EP0087161A3 (en) * | 1982-02-24 | 1984-04-04 | Key Pharmaceuticals, Inc. | Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament |
| US5232700A (en) * | 1990-11-14 | 1993-08-03 | The Administrators Of The Tulane Educational Fund | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
| NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| US6045823A (en) * | 1996-09-19 | 2000-04-04 | Dragoco Gerberding & Co. Ag | Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same |
| GB9902227D0 (en) * | 1999-02-01 | 1999-03-24 | Cipla Limited | Pharmaceutical composition for topical administration |
| US8030260B2 (en) * | 2005-03-25 | 2011-10-04 | Chemsil Silicones, Inc | Pre-shave compositions and methods of using same |
| DE202005007363U1 (de) | 2005-05-04 | 2005-07-14 | Anton Hübner GmbH & Co. KG | Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen |
| BRPI0806633A2 (pt) | 2007-01-17 | 2011-09-06 | Devirex Ag | composição em gel, composição em spray, composição em gel nasal, composição de bálsamo labial, composição emulsificada, composição farmacêutica ou cosmética para aplicação em um local onda há uma infecção viral primária ativa ou um local conhecido que exibe uma infecção viral recorrente |
| DK2563374T3 (da) | 2010-07-08 | 2014-01-20 | Devirex Ag | Polyethylenglycolsammensætninger til kontrol af tilbagefald af herpes labialis, herpes genitalis og herpes zoster |
| WO2013102885A1 (en) | 2012-01-06 | 2013-07-11 | Devirex Ag | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
-
2011
- 2011-07-08 DK DK11754919.6T patent/DK2563374T3/da active
- 2011-07-08 SG SG2013000823A patent/SG186937A1/en unknown
- 2011-07-08 MX MX2012014783A patent/MX2012014783A/es active IP Right Grant
- 2011-07-08 ES ES11754919.6T patent/ES2442928T3/es active Active
- 2011-07-08 AU AU2011275458A patent/AU2011275458B2/en active Active
- 2011-07-08 WO PCT/IB2011/001919 patent/WO2012004669A1/en active Application Filing
- 2011-07-08 RS RS20140058A patent/RS53162B/en unknown
- 2011-07-08 PL PL11754919T patent/PL2563374T3/pl unknown
- 2011-07-08 CA CA2803228A patent/CA2803228C/en active Active
- 2011-07-08 KR KR1020137002574A patent/KR101881175B1/ko active IP Right Grant
- 2011-07-08 US US13/704,061 patent/US9814743B2/en active Active
- 2011-07-08 JP JP2013517583A patent/JP5858994B2/ja active Active
- 2011-07-08 EP EP11754919.6A patent/EP2563374B1/en active Active
- 2011-07-08 SI SI201130086T patent/SI2563374T1/sl unknown
- 2011-07-08 PT PT117549196T patent/PT2563374E/pt unknown
- 2011-07-08 CN CN201180033948.1A patent/CN103079574B/zh active Active
- 2011-07-08 RU RU2013100383A patent/RU2643763C2/ru active
-
2012
- 2012-12-12 IL IL223582A patent/IL223582A/en active IP Right Grant
-
2013
- 2013-01-08 ZA ZA2013/00177A patent/ZA201300177B/en unknown
- 2013-07-16 HK HK13108347.8A patent/HK1180969A1/xx unknown
-
2014
- 2014-02-12 HR HRP20140135AT patent/HRP20140135T1/hr unknown
-
2017
- 2017-11-06 US US15/804,961 patent/US20180055875A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530208A5 (ja) | ||
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| JP2012515184A5 (ja) | ||
| JP2014530220A5 (ja) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| JP2014530874A5 (ja) | ||
| EP4316488A3 (en) | Methods and compositions for treatment of attention deficit disorder | |
| EP4353254A3 (en) | Methods for treating skin infection by administering an il-4r antagonist | |
| JP2013518057A5 (ja) | ||
| EP3251674A3 (en) | Antiviral azasugar-containing nucleosides | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| JP2013231087A5 (ja) | ||
| HRP20191723T1 (hr) | Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa | |
| JP2012517478A5 (ja) | ||
| JP2009542581A5 (ja) | ||
| WO2012136934A3 (fr) | Composition cicatrisante pour application topique. | |
| JP2014526559A5 (ja) | ||
| RU2013100383A (ru) | Композиции полиэтиленгликоля для контроля рецидивов лабиального герпеса, генитального герпеса и опоясывающего герпеса | |
| WO2012161497A3 (ko) | 보습능이 우수한 펩타이드 유도체 및 이의 용도 | |
| WO2013019091A3 (en) | A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
| JP2015507020A5 (ja) | ||
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| JP2013533867A5 (ja) |